NL-OMON20712招募中不适用
A precision medicine approach to predict chemotherapy sensitivity in ascites of ovarian cancer patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Radboudumc
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •-Histologically confirmed ovarian, tubal or extra-ovarian peritoneal cancer
排除标准
- •-Previous chemotherapy
- •-Previous or concurrent malignant disease except basal cell carcinoma
研究者
相似试验
进行中（未招募）
不适用
The Hurria Older PatiEnts (HOPE) With Breast Cancer StudyBreast CancerNCT01472094City of Hope Medical Center700
招募中
不适用
Establishment of the method for predicting clinical effect of tocilizumab based on its serum concentration in rheumatoid arthritis patientsrheumatoid arthritisJPRN-UMIN000041153Department of Hospital pharmacy Hamamatsu University School of Medicine50
尚未招募
2 期
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid CancerLocally Advanced Thyroid Gland CarcinomaThyroid CancerNCT06713057West China Hospital20
招募中
不适用
Prediction of the effect of chemotherapy and prognosis based on gene and metabolome analysis by specimen collected by EUSFNA on pancreatic cancerpancreatic cancerJPRN-UMIN000026261Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine250
已完成
不适用
Establishment of prediction method of malignancy and treatment resistance by fibrotic stroma quantification of pancreatic cancer using iodine mapPancreatic cancerJPRN-UMIN000036842kobe university162